News

SEC Filings

Document Details

Form
Filing Date
July 15, 2020
Document Date
July 13, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Nolan Mangini Siobhan

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com